资讯
The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...
Chronic pain is defined as pain that persists beyond acute pain, typically over six months. It can be initiated with an injury or disease, but may persist after the triggering injury has healed.
Explore how AI-powered wireless implants could replace opioids, using ultrasonic energy to block chronic pain signals without addiction risk.
Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS 6 system from an existing customer in the United States. The customer is an experienced user of the Nexstim therapy ...
Shares of Artelo Biosciences rose after the company reported positive data for its first in-human trial for a potential non-opioid treatment for persistent pain. The stock more than doubled to $16.30 ...
6 天
Stocktwits on MSNArtelo Biosciences Stock Doubles After Positive Results In First Non-Opioid Pain Treatment ...Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...
This broad-spectrum CBD pain cream is available in 1,000 mg and comes in a 2.5 fluid ounce (fl oz) tube. The company claims the formula is anti-inflammatory and may be suitable for localized pain ...
Association between chronic pain and substance use Rezaul Karim Ripon Nasim Maleki Research Open Access 01 Jul 2025 Scientific Reports Volume: 15, P: 22038 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果